{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:28:16Z","timestamp":1781220496246,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 17K08483"],"award-info":[{"award-number":["JP 17K08483"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.seizure.2019.10.013","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T12:53:35Z","timestamp":1571835215000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study"],"prefix":"10.1016","volume":"73","author":[{"given":"Yoshiaki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2019.10.013_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14740338.2017.1248399","article-title":"Hyponatremia induced by antiepileptic drugs in patients with epilepsy","volume":"16","author":"Lu","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.seizure.2019.10.013_bib0010","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/jbmr.380","article-title":"Mild hyponatremia as a risk factor for fractures: the Rotterdam Study","volume":"26","author":"Hoorn","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.seizure.2019.10.013_bib0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/ki.2012.459","article-title":"Mild hyponatremia is associated with an increased risk of death in an ambulatory setting","volume":"83","author":"Gankam-Kengne","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.seizure.2019.10.013_bib0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1528-1167.2010.02939.x","article-title":"Hyponatremia and risk of seizures: a retrospective cross-sectional study","volume":"52","author":"Halawa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.013_bib0025","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.10.013_bib0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1528-1157.1984.tb04205.x","article-title":"Carbamazepine and serum sodium levels","volume":"25","author":"Kalff","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.013_bib0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/clpt.1985.115","article-title":"Hyponatremia during carbamazepine therapy","volume":"37","author":"Lahr","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2019.10.013_bib0040","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1345\/aph.1G209","article-title":"Carbamazepine-induced hyponatremia: assessment of risk factors","volume":"39","author":"Kuz","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.seizure.2019.10.013_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2788.2001.00338.x","article-title":"Hyponatremia during carbamazepine therapy in patients with intellectual disability","volume":"45","author":"Kelly","year":"2001","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.seizure.2019.10.013_bib0050","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.0013-9580.2004.00604.x","article-title":"Hyponatremia due to an additive effect of carbamazepine and thiazide diuretics","volume":"45","author":"Ranta","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.013_bib0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2169\/internalmedicine.40.459","article-title":"Severe hyponatremia in a patient treated\u3000with levomepromazine and carbamazepine","volume":"40","author":"Matsumura","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.seizure.2019.10.013_bib0060","first-page":"21","article-title":"Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: a case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy","volume":"1","author":"Tanaka","year":"2008","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.seizure.2019.10.013_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/11318950-000000000-00000","article-title":"Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case\/non-case analysis of vigibase","volume":"33","author":"Beers","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.seizure.2019.10.013_bib0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410430219","article-title":"Hyponatremia due to sodium valproate","volume":"43","author":"Branten","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2019.10.013_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(00)02613-1","article-title":"Hyponatraemia associated with lamotrigine in cranial diabetes insipidus","volume":"356","author":"Mewasingh","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2019.10.013_bib0080","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1528-1167.2005.64004.x","article-title":"Hyponatremia associated with repeated use of levetiracetam","volume":"46","author":"Nasrallah","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.013_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2018.04.025","article-title":"Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study","volume":"59","author":"Falhammar","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.10.013_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.03.023","article-title":"Antiepileptic drugs-induced hyponatremia: review and analysis of 560 hospitalized patients","volume":"143","author":"Intravooth","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.10.013_bib0095","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/epi.13777","article-title":"EpiPGX Consortium. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy","volume":"58","author":"Berghuis","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.10.013_bib0100","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/ene.13069","article-title":"Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia","volume":"23","author":"Berghuis","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2019.10.013_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","article-title":"Clinically significant pharmacokinetic drug interactions with carbamazepine. An update","volume":"31","author":"Spina","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.seizure.2019.10.013_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000117315","article-title":"Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents","volume":"30","author":"Rambeck","year":"1990","journal-title":"Eur Neurol"},{"key":"10.1016\/j.seizure.2019.10.013_bib0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-005-0056-0","article-title":"Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction","volume":"61","author":"Benedetti","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2019.10.013_bib0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chest.2017.07.030","article-title":"The use of\u3000benzodiazepine receptor agonists and the risk of hospitalization for pneumonia: a\u3000nationwide population-based nested case-control study","volume":"153","author":"Chen","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.seizure.2019.10.013_bib0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.1995.00430090099011","article-title":"Risk factors for the development of hyponatremia in psychiatric inpatients","volume":"155","author":"Siegler","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.seizure.2019.10.013_bib0130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/JCP.0b013e3182a4736f","article-title":"Epidemiology, symptoms, and treatment characteristics of hyponatremic\u3000psychiatric inpatients","volume":"33","author":"Lange-Asschenfeldt","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.seizure.2019.10.013_bib0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2018.11.011","article-title":"Mannheimer B.\u3000Antipsychotics and severe hyponatremia: a Swedish population-based case-control study","volume":"60","author":"Falhammar","year":"2019","journal-title":"Eur J Intern Med"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119304972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131119304972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:53:32Z","timestamp":1761011612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131119304972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"alternative-id":["S1059131119304972"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.10.013","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}